Healthcare & Pharmaceutical Market Intelligence
Ghana has established itself as one of the most structured pharmaceutical markets in West Africa, combining a well-developed regulatory environment, growing domestic pharmaceutical manufacturing, expanding regional exports, and a rapidly evolving fertility healthcare ecosystem.
35M+
Population (2025)
USD 447M
Pharma Imports (2024)
70–80%
Import Share
≈USD 700M
Pharma Market (2024)
15.8%
Self-Reported Male Infertility
A balanced system of imports, local manufacturing & regional exports
Key Market Indicators
≈USD 700M
Formal Pharmaceutical Market (2024)
USD 120–220M
Dietary Supplements (≈8–10% CAGR)
USD 50–95M
Fertility Market
20–30%
Local Manufacturing
USD 447M Imports • USD 14.8M Exports
Female Infertility Clinical Profile • 1,140 Women Evaluated
43.6%
Tubal blockage (Korle-Bu Teaching Hospital)
52.4%
Secondary infertility (Korle-Bu Teaching Hospital)
25.4%
Fibroids
11.8%
Self-reported infertility among women (community study, ages 15–49)
15.8%
Self-reported infertility among men (community study, ages 15–49)
Sources: Korle-Bu Teaching Hospital • Community-Based Ghana Study (2,179 men & women) • Hydrosalpinx 13.4% • PCOS benchmark 10–13% (WHO) • OEC (HS30) 2024 • Ghana FDA • World Bank
Key Drivers
Increasing delayed childbearing
Rising lifestyle-related infertility factors
Growing acceptance of ART
Expanding private fertility clinic ecosystem
Strong urban demand for nutraceuticals (Accra, Kumasi)
Structured hybrid pharma market: imports, manufacturing & regional exports
One of the strongest manufacturing ecosystems in West Africa after Nigeria
Regional trade bridge serving Anglophone & Francophone West Africa
High pharmacy penetration & structured retail system
Expanding IVF infrastructure & growing private fertility clinics
